The University of Chicago Header Logo

SMO mutations confer poor prognosis in malignant pleural mesothelioma.

SMO mutations confer poor prognosis in malignant pleural mesothelioma. Transl Lung Cancer Res. 2020 Oct; 9(5):1940-1951.

View in: PubMed